LakhmirS.ChawlaMD

Critical Care

Chief Medical Officer, La Jolla Pharmaceutical Company; Prof Anesthesiology & Critical Care Medicine, G Washington University School of Medicine & Hlth Sci

Join to view full profile

Dr. Chawla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chawla's full profile

Already have an account?

Office
900 23rd St Nw
Suite G- 2092
Washington, DC 20037
Phone+1 202-715-4750

Education & Training

George Washington University School of MedicineFellowship, Critical Care Medicine, 2001 - 2002
George Washington UniversityFellowship, Nephrology, 1999 - 2001
George Washington UniversityResidency, Internal Medicine, 1995 - 1998
Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

CA State Medical License 2016 - 2025
DC State Medical License 1998 - 2018
MD State Medical License 1998 - 2002

Awards, Honors, & Recognition

International Vicenza Award for Critical Care Nephrology 33rd Course on Critical Care Nephrology, 2015

Clinical Trials

Protocolized Care for Early Septic Shock Start of enrollment: 2008 Mar 01
Completed
Not Applicable
Protocol to Assess the Severity of Acute Kidney Injury Start of enrollment: 2008 Apr 01
Completed
Not Applicable
Safety and Dose Finding Study of Xigris in Hemodialysis Patients Start of enrollment: 2008 Oct 01
Completed
Phase 2
The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury Start of enrollment: 2010 Dec 01
Completed
Not Applicable
Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study Start of enrollment: 2011 Jul 01
Completed
Phase 1
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery Start of enrollment: 2013 Jun 01
Completed
Join now to see all

Publications & Presentations

PubMed

Synthetic Angiotensin II ameliorates alterations of systemic hemodynamics, microcirculatory deterioration, and renal damage in septic rats.
Bulent Ergin, Aysegul Kapucu, Lakhmir Chawla, Can Ince
Microvascular Research. 2024-09-01
6 citations
ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock.
Daniel E Leisman, Damian R Handisides, Laurence W Busse, Mark C Chappell, Lakhmir S Chawla
Critical Care. 2024-04-18
1 citations
CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury.
Sevag Demirjian, Lakhmir Chawla, Danielle Davison, Lui G Forni, Michael Heung
Blood Purification. 2024-01-01

Journal Articles

Global Epidemiology and Outcomes of Acute Kidney Injury
Lakhmir S Chawla, John A Kellum, Paul M Palevsky, Stuart L Goldstein, Jorge Cerda, Nature

Press Mentions

ExThera Blood Filter Used to Treat Covid-19March 27th, 2020
Dead yet Conscious: Some CPR Survivors Recall Events During Heart FailureDecember 26th, 2023
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)June 28th, 2024
Join now to see all